Bookmark! (press Ctrl+D)

Singapore’s Agency for Science, Technology and Research (A*STAR) is working with Japan’s Chugai Group to come up with a therapeutic antibody to treat those with COVID-19. Professor Sir David Lane, A*STAR chief scientist and chairman of Chugai Pharmabody Research, explained the role of antibodies in treating COVID-19 infections.

Subscribe to our channel here: https://cna.asia/youtubesub

Subscribe to our news service on Telegram: https://cna.asia/telegram

Follow us:
CNA: https://cna.asia
CNA Lifestyle: http://www.cnalifestyle.com
Facebook: https://www.facebook.com/channelnewsasia
Instagram: https://www.instagram.com/channelnewsasia
Twitter: https://www.twitter.com/channelnewsasia

source

LEAVE A REPLY

Please enter your comment!
Please enter your name here